Sino Biopharmaceutical (HKSE:01177) Total Tax Payable : HK$564 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Sino Biopharmaceutical Total Tax Payable?

Sino Biopharmaceutical's Total Tax Payable for the quarter that ended in Dec. 2023 was HK$564 Mil.

Sino Biopharmaceutical's quarterly Total Tax Payable declined from Dec. 2022 (HK$370 Mil) to Jun. 2023 (HK$195 Mil) but then increased from Jun. 2023 (HK$195 Mil) to Dec. 2023 (HK$564 Mil).

Sino Biopharmaceutical's annual Total Tax Payable declined from Dec. 2021 (HK$421 Mil) to Dec. 2022 (HK$370 Mil) but then increased from Dec. 2022 (HK$370 Mil) to Dec. 2023 (HK$564 Mil).

Sino Biopharmaceutical Total Tax Payable Historical Data

The historical data trend for Sino Biopharmaceutical's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Total Tax Payable Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

355.23

315.49

420.79

369.51

564.40

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Tax Payable	Get a 7-Day Free Trial															420.79	117.40	369.51	194.78	564.40

Sino Biopharmaceutical Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Sino Biopharmaceutical Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (HKSE:01177) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (HKSE:01177) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

SBHMY:USA SBMFF:USA SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Sino Biopharmaceutical (HKSE:01177) Headlines

No Headlines